Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Jan
4
2018
Cannabis Chaos: Justice Department Revokes Obama-Era Guidance on Marijuana Enforcement McDermott Will & Emery
Jan
4
2018
Ninth Circuit Simultaneously Denies Motion to Dismiss Without Prejudice and Grants Motion to Expedite in Chlorpyrifos Litigation Bergeson & Campbell, P.C.
Jan
4
2018
French Competition Authority Fines a Pharmaceutical Laboratory EUR 25 Million for Anti-Generic Practices McDermott Will & Emery
Jan
4
2018
Arkansas State Plant Board Votes to Keep Dicamba Ban in Place Bergeson & Campbell, P.C.
Jan
4
2018
Congress Weighs Bill to Combat Food Fraud Keller and Heckman LLP
Jan
3
2018
Recent OCR Action Provides HIPAA Guidance Related to Opioid Crisis and Privacy Rule in Research Faegre Drinker
Jan
3
2018
EPA to Host Two Webinars on Generating and Entering the Annual Report into CDX for Third-Party Certifiers Bergeson & Campbell, P.C.
Jan
3
2018
Oncology Services Provider Reaches $2.3 Million Settlement with HHS for Data Breach Faegre Drinker
Jan
3
2018
OIG Report Finds FDA Recall Process is Slow Keller and Heckman LLP
Jan
3
2018
New Trial Ordered Where Jury’s Verdict Didn’t “Gel” Proskauer Rose LLP
Jan
3
2018
FDA Issues Amended Final Guidance on Medical Device Accessories Barnes & Thornburg LLP
Jan
3
2018
FDA Resets Enforcement Priorities for OTC Homeopathic Drugs Mintz
Jan
2
2018
EPA Concludes Glyphosate is Not Likely to be Carcinogenic to Humans Greenberg Traurig, LLP
Jan
2
2018
Texas Court Affirms Constitutionality of Statute Prohibiting Brewers from Selling Distribution Rights to Their Products McDermott Will & Emery
Jan
2
2018
Soda Tax Battles Continue into 2018 Keller and Heckman LLP
Dec
29
2017
n-Hexane Listed as a Reproductive Toxicant under Prop 65 Keller and Heckman LLP
Dec
27
2017
TTB Updates to the Semi-Annual Regulatory Agenda McDermott Will & Emery
Dec
23
2017
FDA Publishes Draft Guidance on Investigational IVDs Used in Therapeutic Product Clinical Trials Covington & Burling LLP
Dec
22
2017
EPA Publishes Final 2018 RFS Requirements Bergeson & Campbell, P.C.
Dec
22
2017
FCIC Intends To Issue Funding Opportunity For Biomass Processing Bergeson & Campbell, P.C.
Dec
21
2017
Top International News in Chemical Policy and Regulation- December 2017: Americas and Asia Bergeson & Campbell, P.C.
Dec
21
2017
Top International News in Chemical Policy and Regulation- December 2017: European Union and United Kingdom Bergeson & Campbell, P.C.
Dec
21
2017
FSIS Releases 2017 Food Safety Data Keller and Heckman LLP
Dec
21
2017
FDA Issues New Draft Guidance on “Least Burdensome” Principles for Medical Devices Faegre Drinker
Dec
21
2017
Compounders Who Skirt The FDA: Who Is The Expert Here? IMS Legal Strategies
Dec
20
2017
Nationwide Pharmacy DaVita Rx to Pay $63.7 Million to Settle Healthcare Fraud Allegations Relating to Improper Billing Practices of Federal Healthcare Programs Tycko & Zavareei LLP
Dec
20
2017
FDA Issues Guidance on Clinical and Patient Decision Support Software Squire Patton Boggs (US) LLP
Dec
20
2017
California Court of Appeal Affirms Judgment Finding No Duty to Defend Drug Manufacturer in Lawsuits Alleging Increased Opioid Usage Sheppard, Mullin, Richter & Hampton LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins